John Bing Sunwoo, MD
Otolaryngologist - General
Highlights
- Board Certified
Biography
John Bing Sunwoo, MD is a Otolaryngologist - General practicing in Saint Louis, MO
He has not yet shared a personalized biography with Doctor.com.
Summary
Provider Training
| University | Degree | Focus | Graduated |
|---|---|---|---|
| Washington University School of Medicine, St. Louis | Other Degree | 1993 | |
| Washington Center / School of Medicine | Other Degree | 1993 |
| Institution | Focus | Year |
|---|---|---|
| Residency - Washington University School Of Medicine | 2003 | |
| Residency - Washington University/B-Jh/Slch Conc, Otolaryngology University Ca Davis Medical Center, General Surgery | Not Specified | |
| Fellowship - National Institutes of Health | 2000 | |
| Fellowship - National Institutes of Health MD | 2000 | |
| Internship - UC Davis Health System | 1994 | |
| Internship - University of California (Davis), Sacramento, CA, Rotating Internship | Not Specified | |
| Internship - UC Davis Health System CA (1994) | Not Specified | |
| Continuing Medical Education (CME) - Washington University, St Louis, MO, Surgery, Head & Neck | Not Specified | |
| Continuing Medical Education (CME) - Washington University, St Louis, MO, Otolaryngology | Not Specified |
| Certification | Cert. Body | Year |
|---|---|---|
| Otolaryngology | Otolaryngology | Not Specified |
| Otolaryngology | Otolaryngology | 2004 |
| Otolaryngology | Otolaryngology | 2004 |
Experience & Accolades
| Position | Organization | Time |
|---|---|---|
| Member | Pigmented Lesion and Melanoma Program, Stanford University School of Medicine | 2011 - 2014 |
| Director | Head and Neck Cancer Research, Stanford University School of Medicine, Dept. of Otolaryngology | 2013 - 2014 |
| Co-Director | Thyroid and Parathyroid Tumor Board, Stanford University School of Medicine | 2011 - 2014 |
| Member | CORE Grants Study Section, American Academy of Otolaryngology - Head and Neck Surgery | 2009 - 2014 |
| Distinction | Institution | Year |
|---|---|---|
| Best Doctors, Inc. | 2009-2014 | |
| Top Doctors, Castle Connolly | 2013-2014 | |
| Faculty Teacher of the Year, Dept. of Otolaryngology, Stanford Univer | 2012 | |
| Best Doctors in America | ||
| K08 Award, National Institutes of Health | 2004 | |
| Chief Resident Teaching Award, Washington University | 2003 | |
| Alpha Omega Alpha, Washington University | 2003 | |
| Young Investigator Award, American Head and Neck Society | 2000 | |
| Resident Research Award, Washington University | 1997, 1997 | |
| Louis and Dorothy Kovitz Prize in Surgery, Washington University | 1993 | |
| Sigma Xi, Brown University | 1989 |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | CANCER | Epstein-Barr Virus Nuclear Antigen 1 | 2014 |
| Other Publication | The Jourl of clinical investigation | Targeting CD137 enhances the efficacy of cetuximab. | |
| Other Publication | Cancer jourl | Cancer immunosurveillance and immunoediting by tural killer cells. | 2013 |
| Other Publication | PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM | Modulation of tural killer cell antitumor activity by the aryl hydrocarbon receptor | 2013 |
| Other Publication | Jourl of toxicology | Epigenetically mediated pathogenic effects of phenthrene on regulatory T cells. | 2013 |
| Other Publication | INTERTIOL IMMUNOLOGY | Identification of human NK cells that are deficient for sigling adaptor FcR gamma | 2012 |
| Other Publication | INTERTIOL FORUM OF ALLERGY & RHINOLOGY | CD44+cells have cancer stem cell-like properties in sopharyngeal carcinoma | 2012 |
| Other Publication | BIOMATERIALS | The manipulation of tural killer cells to target tumor sites using magnetic noparticles | 2012 |
| Other Publication | Kohrt, H. E., Houot, R., Weiskopf, K., Goldstein, M., Lund, P., Scheer | Effect of stimulation of tural killer cells with an anti-CD137 mAb on the efficacy of trastuzumab | |
| Other Publication | PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM | The CD47-sigl regulatory protein alpha | 2012 |
| Other Publication | INTERTIOL FORUM OF ALLERGY & RHINOLOGY | Targeted endoscopic salvage sopharyngectomy for recurrent sopharyngeal carcinoma | 2012 |
| Other Publication | PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM | Distal-less homeobox transcription factors regulate development | 2008 |
| Other Publication | PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM | HLA alleles determine differences in human tural killer cell responsiveness and potency | 2008 |
| Other Publication | HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N | Spontaneous regression of cutaneous head and neck melanoma | 2008 |
| Other Publication | ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY | Mycotic pseudoaneurysm of the interl maxillary artery - Case report and review of the literature | 2007 |
| Other Publication | BLOOD | Arrested tural killer cell development associated with transgene insertion into the Atf2 locus | 2006 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Inhibition of nuclear factor-kappa B | 2005 |
| Other Publication | TURE | Licensing of tural killer cells by host major histocompatibility complex class I molecules | 2005 |
| Other Publication | CANCER RESEARCH | Nuclear factor-kappa B is an important modulator of the altered gene expression profile | 2004 |
| Other Publication | INTERTIOL JOURL OF CANCER | Effects of pharmacologic antagonists of epidermal growth factor receptor | 2002 |
| Other Publication | JOURL OF CLINICAL ONCOLOGY | Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer | 2001 |
| Other Publication | INTERTIOL JOURL OF CANCER | Multiple regions of deletion on chromosome arm 13q in head-and-neck squamous-cell carcinoma | 1999 |
| Other Publication | JOURL OF THE TIOL CANCER INSTITUTE | Chromosome 8 allelic loss | 1996 |
| Other Publication | TURE | CELL-CYCLE OSCILLATION OF PHOSPHATASE INHIBITOR | 1990 |
| Other Publication | CANCER | Epstein-Barr Virus Nuclear Antigen 1 | 2014 |
| Other Publication | The Journal of clinical investigation | Targeting CD137 enhances the efficacy of cetuximab. | |
| Other Publication | Cancer journal | Cancer immunosurveillance and immunoediting by natural killer cells. | 2013 |
| Other Publication | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O | Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor | 2013 |
| Other Publication | CANCER | Impact of positron emission tomography | 2013 |
| Other Publication | Journal of toxicology | Epigenetically mediated pathogenic effects of phenanthrene on regulatory T cells. | 2013 |
| Other Publication | INTERNATIONAL IMMUNOLOGY | Identification of human NK cells that are deficient for signaling adaptor FcR gamma | 2012 |
| Other Publication | INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY | CD44+cells have cancer stem cell-like properties in nasopharyngeal carcinoma | 2012 |
| Other Publication | BIOMATERIALS | The manipulation of natural killer cells to target tumor sites using magnetic nanoparticles | 2012 |
| Other Publication | Kohrt, H. E., Houot, R., Weiskopf, K., Goldstein, M., Lund, P., Scheer | Effect of stimulation of natural killer cells with an anti-CD137 mAb on the efficacy of trastuzumab | |
| Other Publication | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O | The CD47-signal regulatory protein alpha | 2012 |
| Other Publication | INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY | Targeted endoscopic salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma | 2012 |
| Other Publication | CANCER RESEARCH | ERK1/2 Regulation of CD44 Modulates Oral Cancer Aggressiveness | 2012 |
| Other Publication | CELL CYCLE | A cisplatin-resistant subpopulation of mesenchymal-like cells in head | 2011 |
| Other Publication | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O | Distal-less homeobox transcription factors regulate development | 2008 |
| Other Publication | LARYNGOSCOPE | Temporal Relationship Between Antitumor Necrosis Factor-alpha Antibody Therapy | 2008 |
| Other Publication | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O | HLA alleles determine differences in human natural killer cell responsiveness and potency | 2008 |
| Other Publication | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND | Spontaneous regression of cutaneous head and neck melanoma | 2008 |
| Other Publication | ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY | Mycotic pseudoaneurysm of the internal maxillary artery - Case report and review of the literature | 2007 |
| Other Publication | BLOOD | Arrested natural killer cell development associated with transgene insertion into the Atf2 locus | 2006 |
| Other Publication | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Inhibition of nuclear factor-kappa B | 2005 |
| Other Publication | NATURE | Licensing of natural killer cells by host major histocompatibility complex class I molecules | 2005 |
| Other Publication | CANCER RESEARCH | Nuclear factor-kappa B is an important modulator of the altered gene expression profile | 2004 |
| Other Publication | INTERNATIONAL JOURNAL OF CANCER | Effects of pharmacologic antagonists of epidermal growth factor receptor | 2002 |
| Other Publication | GENOMICS | Transcript map of the 8p23 putative tumor suppressor region | 2001 |
| Other Publication | CLINICAL CANCER RESEARCH | IL (interleukin)-1 alpha promotes nuclear factor-kappa B and AP-1-induced IL-8 expression | 2001 |
| Other Publication | CLINICAL CANCER RESEARCH | Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival | 2001 |
| Other Publication | CLINICAL CANCER RESEARCH | Coexpression of proangiogenic factors IL | 2001 |
| Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer | 2001 |
| Other Publication | GENOMICS | Homozygous deletions define a region of 8p23.2 containing a putative tumor suppressor gene | 1999 |
| Other Publication | INTERNATIONAL JOURNAL OF CANCER | Multiple regions of deletion on chromosome arm 13q in head-and-neck squamous-cell carcinoma | 1999 |
| Other Publication | MOLECULAR CARCINOGENESIS | Constitutive activation of transcription factors NF-kappa B, AP-1 | 1999 |
| Other Publication | ONCOGENE | Localization of a putative tumor suppressor gene in the sub-telomeric region of chromosome 8p | 1999 |
| Other Publication | OTOLARYNGOLOGY-HEAD AND NECK SURGERY | Clinical correlations with allelotype in supraglottic squamous cancer | 1998 |
| Other Publication | JOURNAL OF THE NATIONAL CANCER INSTITUTE | Chromosome 8 allelic loss | 1996 |
| Other Publication | GENES CHROMOSOMES & CANCER | Evidence for multiple tumor suppressor genes on chromosome arm 8p in supraglottic laryngeal cancer | 1996 |
| Other Publication | NATURE | CELL-CYCLE OSCILLATION OF PHOSPHATASE INHIBITOR | 1990 |
Photos


Specialties
Languages Spoken
EnglishMedical Specialties
- Otolaryngologist
Accepts New Patients: Yes
Payment Options
Payment DetailsReviews
Average Rating:
Number of Reviews: 0
Most Recent Review: None
Number of Reviews: 0
Most Recent Review: None
Office & Staff Evaluation Not rated
Not rated
Not rated
Not rated
Not rated
Not Rated
Locations
Affiliated Practices
Practice At 4921 Parkview Pl 11a
4921 Parkview Pl 11aSaint Louis, MO 63110
Medical Spec Clnc Stanford END
300 Pasteur DrPalo Alto, CA 94304
Practice Colleagues
Michelle Ocampo, - Certified Registered Nurse Anesthetist
Natalie Bodmer, MD - Anesthesiologist
Marc Berenson, MD - Emergency Medicine Physician
Thomas Dieringer, MD - Internal Medicine Physician
Dr Eric Keller, MD, MA - Diagnostic Radiologist
Kelli Moran-miller, PHD - Psychologist
Alisa Dea, PA-C - Physician Assistant
Chelsea Cooman, DPT - Physical Therapist
Erin Brockman, PA-C - Physician Assistant
Jessica Ansari, MD - Anesthesiologist
Procedures & Services
Procedures & Treatments Offered
Commonly Prescribed Medications
John Bing Sunwoo, MD has not yet listed the medications that he commonly prescribes.
Accepted Insurance
Accepted Insurance
John Bing Sunwoo, MD has not yet specified the insurance plans he accepts.